By Stephen Nakrosis 

Novo Nordisk A/S on Friday said it was recalling certain product samples in the U.S. that had been stored at temperatures below their storage requirements.

The company said 1,468 product samples of Levemir, Tresiba, Fiasp, Novolog and Xultophy were being recalled.

Novo Nordisk hasn't received reports of serious adverse events or injuries related to the recall, it said.

"This recall only impacts product samples and does not impact product that has been broadly distributed to pharmacies or mail-order services," the company said.

The company also said the recall is being conducted with the knowledge of the U.S. Food and Drug Administration.


--Write to Stephen Nakrosis at


(END) Dow Jones Newswires

May 07, 2021 16:38 ET (20:38 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.